Showing results (11-20 of 59) with videos related to
Sort By:
Pageof 6
Advances in Neurology|January 1, 1993
Clinical heterogeneity of dopa-responsive dystonia: PET observationsH Takahashi, B J Snow, T G Nygaard, et al.Annals of Neurology|January 1, 1997
Which clinical sign of Parkinson's disease best reflects the nigrostriatal lesion?F J Vingerhoets, M Schulzer, D B Calne, et al.Archives of Neurology|October 21, 1998
Long-term follow-up of levodopa responsiveness in generalized dystoniaR B Dewey, M D Muenter, A Kishore, et al.Movement Disorders : Official Journal of the Movement Disorder Society|January 1, 1990
A case of rabies in North AmericaM Bhatt, E Wolters, J Tsui, et al.The American Journal of Clinical Nutrition|March 1, 1990
Plasma glucose and insulin responses to traditional Pima Indian mealsJ C Brand, B J Snow, G P Nabhan, et al.Journal of Neurology, Neurosurgery, and Psychiatry|January 1, 1991
The nigrostriatal dopaminergic pathway in Wilson's disease studied with positron emission tomographyB J Snow, M Bhatt, W R Martin, et al.European Journal of Neurology|July 17, 2010
Botulinum toxin assessment, intervention and after-care for upper limb hypertonicity in adults: international consensus statementG Sheean, N A Lannin, L Turner-Stokes, et al.Parkinsonism & Related Disorders|January 1, 1997
Positron emission tomography (PET) measurements of striatal D(2) receptors in untreated Parkinson's disease patients with follow-up after 6 and 12 months' treatment with SINEMET((R)) or SINEMET((R)) CRR J Uitti, F J Vingerhoets, M Hayward, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|March 1, 1996
Reproducibility and discriminating ability of fluorine-18-6-fluoro-L-Dopa PET in Parkinson's diseaseF J Vingerhoets, M Schulzer, T J Ruth, et al.Archives of Neurology|April 1, 1991
Positron emission tomography in progressive supranuclear palsyM H Bhatt, B J Snow, W R Martin, et al.Pageof 6